Literature DB >> 17035444

Epithelial mucin stores are increased in the large airways of smokers with airflow obstruction.

Anh L Innes1, Prescott G Woodruff, Ronald E Ferrando, Samantha Donnelly, Gregory M Dolganov, Stephen C Lazarus, John V Fahy.   

Abstract

BACKGROUND: Habitual cigarette smoking is associated with chronic mucus hypersecretion, but the relationship between mucus abnormalities and airflow obstruction in smokers is uncertain.
METHODS: We collected bronchial biopsy samples and epithelial brushings from 24 smokers with and without airflow obstruction and 19 nonsmoking healthy control subjects. Epithelial mucin stores, mucin immunostains, and goblet cell morphology were quantified in bronchial biopsy samples using stereology, and mucin gene expression was quantified in epithelial brushings using real-time reverse transcriptase-polymerase chain reaction.
RESULTS: Goblet cell size and number were higher than normal in smokers (both p < 0.05), leading to a 2.2-fold increase in the volume of stored mucin in the epithelium per surface area of basal lamina (1.94 +/- 0.31 microm(3)/microm(2) vs 4.32 +/- 0.55 microm(3)/microm(2) in control subjects vs smokers, p = 0.001). The increase in stored mucin occurred because of an increase in MUC5AC (p = 0.018) and despite a decrease in MUC5B (p < 0.0001). Stored mucin was significantly higher in the subgroup of smokers with airflow obstruction (p = 0.029) and correlated with FEV(1)/FVC even when controlling for diffusing capacity as a measure of emphysema (p = 0.034).
CONCLUSIONS: Epithelial mucin stores are increased in habitual smokers because of goblet cell hypertrophy and hyperplasia, and the pattern of mucin gene expression is abnormal. The highest epithelial mucin stores are found in smokers with airflow obstruction, suggesting a mechanistic link between epithelial mucin dysregulation and airflow obstruction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035444     DOI: 10.1378/chest.130.4.1102

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  71 in total

1.  Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma.

Authors:  Ryan H Dougherty; Sukhvinder S Sidhu; Kavita Raman; Margaret Solon; Owen D Solberg; George H Caughey; Prescott G Woodruff; John V Fahy
Journal:  J Allergy Clin Immunol       Date:  2010-05       Impact factor: 10.793

2.  MCP-1/CCR2B-dependent loop upregulates MUC5AC and MUC5B in human airway epithelium.

Authors:  Maria E Monzon; Rosanna Malbrán Forteza; S Marina Casalino-Matsuda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-19       Impact factor: 5.464

3.  T-helper type 2-driven inflammation defines major subphenotypes of asthma.

Authors:  Prescott G Woodruff; Barmak Modrek; David F Choy; Guiquan Jia; Alexander R Abbas; Almut Ellwanger; Laura L Koth; Joseph R Arron; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2009-05-29       Impact factor: 21.405

Review 4.  Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.

Authors:  Christopher M Evans; Tasha E Fingerlin; Marvin I Schwarz; David Lynch; Jonathan Kurche; Laura Warg; Ivana V Yang; David A Schwartz
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

5.  The Relationship of Mucus Concentration (Hydration) to Mucus Osmotic Pressure and Transport in Chronic Bronchitis.

Authors:  Wayne H Anderson; Raymond D Coakley; Brian Button; Ashley G Henderson; Kirby L Zeman; Neil E Alexis; David B Peden; Eduardo R Lazarowski; C William Davis; Summer Bailey; Fred Fuller; Martha Almond; Bahjat Qaqish; Elena Bordonali; Michael Rubinstein; William D Bennett; Mehmet Kesimer; Richard C Boucher
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

Review 6.  Fibrotic response of tissue remodeling in COPD.

Authors:  Lina María Salazar; Ana Milena Herrera
Journal:  Lung       Date:  2011-02-02       Impact factor: 2.584

7.  Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy.

Authors:  MeiLan K Han; Nabihah Tayob; Susan Murray; Mark T Dransfield; George Washko; Paul D Scanlon; Gerard J Criner; Richard Casaburi; John Connett; Stephen C Lazarus; Richard Albert; Prescott Woodruff; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2014-06-15       Impact factor: 21.405

8.  Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes.

Authors:  Rongrong Wei; Chong Li; Min Zhang; Yava L Jones-Hall; Jamie L Myers; Imre Noth; Wanqing Liu
Journal:  Transl Res       Date:  2013-12-17       Impact factor: 7.012

9.  IL1RL1 asthma risk variants regulate airway type 2 inflammation.

Authors:  Erin D Gordon; Joe Palandra; Agata Wesolowska-Andersen; Lando Ringel; Cydney L Rios; Marrah E Lachowicz-Scroggins; Louis Z Sharp; Jamie L Everman; Hannah J MacLeod; Jae W Lee; Robert J Mason; Michael A Matthay; Richard T Sheldon; Michael C Peters; Karl H Nocka; John V Fahy; Max A Seibold
Journal:  JCI Insight       Date:  2016-09-08

10.  Modulation of expression in BEAS-2B airway epithelial cells of α-L-fucosidase A1 and A2 by Th1 and Th2 cytokines, and overexpression of α-L-fucosidase 2.

Authors:  Anna D Sobkowicz; Mary E Gallagher; Colm J Reid; Daniel Crean; Stephen D Carrington; Jane A Irwin
Journal:  Mol Cell Biochem       Date:  2014-01-28       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.